| 发明名称 |
THERAPEUTIC DOSING OF A NEUREGULIN OR A SUBSEQUENCE THEREOF FOR TREATMENT OR PROPHYLAXIS OF HEART FAILURE |
| 摘要 |
The invention relates to treatment of heart failure in a mammal. Accordingly, the invention is directed to establishing a dosing regimen whereby the therapeutic benefits conferred by administration of a neuregulin such as glial growth factor 2 (GGF2) or a subsequence thereof are maintained and/or enhanced, while concomitantly minimizing any potential side effects. |
| 申请公布号 |
AU2015202877(B2) |
申请公布日期 |
2017.03.09 |
| 申请号 |
AU20150202877 |
申请日期 |
2015.05.27 |
| 申请人 |
Acorda Therapeutics, Inc. |
发明人 |
Caggiano, Anthony;Ganguly, Anindita;Iaci, Jennifer;Parry, Tom |
| 分类号 |
A61K38/18;A61P9/00 |
主分类号 |
A61K38/18 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
